- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Big Data Analytics in the Healthcare Sector to Grow Over $34.27 Billion by 2022
RESEARCH and MARKETS has announced the release of a new report, “Global Big Data in Healthcare — Estimates & Forecast, 2015-2022.” The report states that Big Data Analytics in the healthcare sector is estimated to grow over $34.27 billion by the end of 2022.
RESEARCH and MARKETS has announced the release of a new report, “Global Big Data in Healthcare — Estimates & Forecast, 2015-2022.” The report states that Big Data Analytics in the healthcare sector is estimated to grow over $34.27 billion by the end of 2022.
According to the press release:
Several forces are triggering the boost in the overall demand for Big Data integration in the healthcare industry. Governmental agencies are encouraging the use of Big Data in the healthcare sector. The Department of Health and Human Services (HHS) under the Health Data Initiative (HDI) is starting to release data from agencies like the Food and Drug Administration (FDA) and the Centers for Disease Control (CDC) in order to access public data of patients for clinical trials and other research activities.
The healthcare industry is in a period of rapid change. Advancements in the fields of genetics, biomedical, and information technology are paving a way towards effective personalized treatments in accordance to the individual characteristics of the patients.
Exploiting these opportunities requires effective usage of Big Data. Over time, healthcare data has been created and accumulated continuously through patient records, radiology images, clinical trials and genomic sequences.
Click here to read the full press release.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.